ArborGen Share Price: Down 52% to $0.07, the World's Biggest Tree-Seedling Supplier on the NZX

ArborGen Share Price Today

The ArborGen share price sits at about $0.07 NZD (NZX: ARB) in mid-June 2026, down roughly 52% over the past year. With a market cap near $37 million, ArborGen Holdings is a small-cap with an outsized global position: it is the world's largest integrated developer and supplier of advanced forestry tree seedlings.

The steep share price fall, and the fact the shares trade below net tangible assets, reflect a difficult patch for a business whose fortunes are tied to the very long cycles of global forestry.

What ArborGen Does

ArborGen is a forestry-genetics company. It breeds, develops, and commercially produces improved tree seedlings (mainly pine and other commercial species) and sells them to forestry operators, primarily in the United States and Brazil, with operations also in Australasia. Better genetics mean faster-growing, higher-yielding trees, which is valuable to plantation owners over a multi-decade rotation.

This is a niche, globally significant business, but one exposed to forestry planting cycles, US housing and timber demand, weather, and currency. Those drivers are long-dated and cyclical, which is part of why a forestry-linked supplier trades so far from the steady-earnings names elsewhere on the NZX. ArborGen's land and asset base gives it more tangible backing than a pure technology micro-cap; it owns productive land in a way loosely comparable to [NZ Rural Land Company](/stocks/nz-rural-land).

Recent Performance

Recent trading has been soft, with revenue down around 4% over the past year and the company reporting a net loss, hence the negative P/E. Over a longer horizon ArborGen had grown revenue at mid-to-high single digits annually, so the recent dip reflects cyclical weakness rather than a structurally broken business. It pays no dividend, reinvesting into its seedling operations and land.

Key Metrics

• •Share price: ~$0.07 NZD
• •Market cap: ~$37 million NZD
• •52-week move: about -52%
• •P/E ratio (trailing): negative (lossmaking)
• •Net tangible assets: ~$0.227 per share (shares trade well below NTA)
• •Gross dividend yield: 0%

The standout here is the gap between the $0.07 share price and $0.227 of net tangible assets per share, a discount of roughly 70%. That asset backing, much of it real land and operations, is the core of any value argument, offset by the cyclical losses and lack of income.

What to Watch

• •US and Brazil forestry demand: Planting activity in ArborGen's key markets, tied to timber and US housing demand, drives seedling sales.
• •Return to profit: The shares are lossmaking now. Evidence of a cyclical recovery in earnings is the key catalyst.
• •Asset realisation: With shares far below NTA, any sale of land or assets, or clearer disclosure of asset value, could help close the discount.
• •Currency: Earnings are offshore, so the NZD/USD and Brazilian real rates matter.

The Bottom Line

ArborGen is a globally important but cyclical forestry-genetics business trading at a deep discount to its tangible assets after a rough year. The bull case is a world-leading niche operator with real land and asset backing available for around a third of stated NTA, with upside if forestry demand recovers. The bear case is ongoing losses, a long and unpredictable forestry cycle, no dividend, and the patience required for the value gap to close. This suits deep-value investors comfortable with cyclical, asset-backed small-caps.

For how we treat NTA discounts and cyclical losses, see our [methodology](/methodology).

*Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice. Stock data may not be real-time. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.*